FALLON LYNNETTE C
SEC Form 4 insider trading activity
FALLON LYNNETTE C has filed 1 SEC Form 4 filing (2 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: May 21, 2026.
On the most recent filing, FALLON LYNNETTE C is listed as Director at ClearPoint Neuro, Inc. Inside the rolling window, FALLON LYNNETTE C reported no open-market purchases and 1 open-market sale totaling $57K in CLPT.
Companies traded
Other insiders at CLPT
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$57K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has FALLON LYNNETTE C made?
FALLON LYNNETTE C has filed 1 SEC Form 4 filing (2 transaction rows) across 1 company since 2026.
Which companies does FALLON LYNNETTE C trade?
FALLON LYNNETTE C has filed SEC Form 4 disclosures for 1 company, including CLPT.
When was FALLON LYNNETTE C's most recent SEC Form 4 filing?
FALLON LYNNETTE C's most recent SEC Form 4 filing on Tracefour is dated May 21, 2026.
What is FALLON LYNNETTE C's total buy and sell value in the current window?
Inside the rolling retention window, FALLON LYNNETTE C bought $0 and sold $57K based on SEC Form 4 filings.
What was FALLON LYNNETTE C's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 5,091 CLPT shares on 2026-05-20, worth $57K, per SEC Form 4 filings.